Press release
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Rising Cancer Burden and Technological Advancements, states DelveInsight
Global Biopsy Devices Market
Biopsy devices play a crucial role in disease diagnosis by enabling tissue and cell sample collection for laboratory examination. While cancer remains the primary focus, these devices are also widely used to assess infectious, inflammatory, and neurological disorders. The increasing prevalence of breast, lung, prostate, and colorectal cancers worldwide has created an urgent need for accurate diagnostic solutions, positioning the biopsy devices market as a critical segment within the global healthcare diagnostics landscape.
Get access to detailed forecasts, segment analysis, and competitive intelligence on the global biopsy devices market. Request Sample Report Now - https://www.delveinsight.com/report-store/biopsy-devices-market?utm_source=openpr&utm_medium=press-release&utm_campaign=apr
Biopsy Devices Market Drivers
Rising Cancer Incidence
Cancer continues to be one of the leading causes of mortality globally, creating sustained demand for biopsy devices. Biopsies remain the gold standard for cancer diagnosis and staging, essential for developing effective treatment strategies. For instance, according to DelveInsight estimates, global breast cancer incidence was approximately 2.29 million cases in 2022 and is projected to increase to 3.36 million cases by 2045, underscoring the importance of advanced diagnostic modalities.
Growing Preference for Minimally Invasive Procedures
Healthcare providers and patients increasingly prefer minimally invasive procedures that reduce pain, recovery time, and complication risks. Techniques such as core needle biopsy, fine-needle aspiration (FNA), vacuum-assisted biopsy (VAB), and image-guided approaches are witnessing widespread adoption. These methods improve diagnostic precision while enhancing patient comfort, fueling demand across hospitals and outpatient facilities.
Technological Advancements
Rapid innovation is reshaping the biopsy devices market. Recent advancements include:
• Vacuum-assisted systems for improved tissue sampling.
• Robotic-assisted biopsy platforms that enhance precision.
• Image-guided biopsy techniques integrated with CT, MRI, and ultrasound.
• AI-powered digital pathology solutions, enabling real-time analysis and diagnostic support.
For instance, in January 2025, Biobot Surgical's Mona Lisa 2.0 robotic system received CE certification. Specifically designed for prostate biopsy and ablation, the system integrates real-time trajectory adjustments to reduce tissue injury and improve procedural accuracy.
Discuss Biopsy Devices market trends, growth drivers, and competitor strategies with our healthcare market experts - https://www.delveinsight.com/sample-request/biopsy-devices-market?utm_source=openpr&utm_medium=press-release&utm_campaign=apr
Biopsy Devices Market Size and Segmentation
• 2024 Market Size: USD 5,813.16 million
• 2032 Market Size Projection: USD 10,812.77 million
• CAGR (2025-2032): 8.09%
The biopsy devices market is moderately to highly consolidated, with leading companies such as Boston Scientific Corporation, Cardinal Health, Medtronic, BD, Cook, Hologic Inc., Olympus Corporation, Fujifilm, B. Braun Melsungen AG, Devicor Medical Products, ARGON Medical, and C. R. Bard spearheading technological innovations and product development activities.
Biopsy Devices Market By Product Type
• Needle-based Biopsy Instruments - Dominating the segment with ~39% share in 2024. Core needle, fine-needle aspiration, and vacuum-assisted devices are increasingly used in cancer and infectious disease diagnosis.
• Biopsy Guidance Systems
• Robotic Biopsy Devices
• Biopsy Accessories
Biopsy Devices Market By Application
• Breast Biopsy - Leading with ~30% market share in 2024, driven by rising global breast cancer incidence and emphasis on early detection.
• Lung Biopsy
• Colorectal Biopsy
• Prostate Biopsy
• Others
Biopsy Devices Market By End-User
• Hospitals - Largest share, owing to high diagnostic procedure volumes and availability of skilled professionals.
• Diagnostic Centers & Imaging Centers
• Ambulatory Surgical Centers
Gain a strategic edge with our in-depth biopsy devices market analysis and custom research solutions. Get Customized Insights - https://www.delveinsight.com/report-store/biopsy-devices-market?utm_source=openpr&utm_medium=press-release&utm_campaign=apr
Biopsy Devices Market Regional Insights
North America Biopsy Devices Market
North America is expected to dominate the global biopsy devices market, accounting for approximately 41% of the total share in 2024. Factors contributing to this leadership include a high prevalence of cancer, well-established healthcare infrastructure, favorable reimbursement policies, and strong adoption of advanced diagnostic technologies. Government-led screening initiatives and the presence of major device manufacturers further strengthen the region's dominance.
According to estimates, North America recorded 306,308 new breast cancer cases in 2022, projected to rise to 384,262 by 2045. Increasing adoption of minimally invasive techniques, along with innovations in AI-powered digital pathology, is propelling regional market growth.
Europe Biopsy Devices Market
Europe is experiencing strong growth due to supportive healthcare infrastructure, government-backed cancer screening programs, and investments in personalized medicine. Breast cancer incidence continues to rise, driving demand for reliable biopsy techniques. Advanced diagnostic technologies and strong clinical adoption are fostering significant opportunities in the region.
Asia-Pacific Biopsy Devices Market
The Asia-Pacific region represents the fastest-growing market for biopsy devices. Rising cancer prevalence, growing awareness of early detection, expanding healthcare infrastructure, and increasing investments in diagnostic facilities are driving adoption. Countries such as China, India, and Japan are emerging as key markets due to large patient pools and rising healthcare expenditure.
Access data-driven insights on biopsy devices market size, segmentation, and regional trends. Download Full Report - https://www.delveinsight.com/sample-request/biopsy-devices-market?utm_source=openpr&utm_medium=press-release&utm_campaign=apr
Biopsy Devices Competitive Landscape
The biopsy devices market is moderately to highly consolidated. Global leaders such as Becton Dickinson, Hologic, Boston Scientific, and Cook Medical dominate through strong R&D pipelines and technological innovation. Strategies such as mergers, acquisitions, partnerships, and new product launches are shaping competition.
• In July 2025, Selio Medical received FDA clearance for its Pre-B. Seal device, the first system designed to reduce post-lung biopsy pneumothorax, improving patient safety.
• In April 2025, ArteraAI Prostate received FDA authorization for its AI-powered pathology tool that predicts long-term prostate cancer outcomes.
• In February 2025, Ibex Medical Analytics secured FDA clearance for its Ibex Prostate Detect, an AI-driven digital pathology solution.
Regional players and startups are also entering the market with cost-effective solutions, targeting emerging economies and niche applications.
Stay updated on how leaders like Boston Scientific, Medtronic, BD, Hologic, and Olympus are reshaping the biopsy devices market with groundbreaking innovations, regulatory approvals, and strategic acquisitions. Discover the Full Competitive Landscape - https://www.delveinsight.com/report-store/biopsy-devices-market?utm_source=openpr&utm_medium=press-release&utm_campaign=apr
Biopsy Devices Market Opportunities and Challenges
Biopsy Devices Market Opportunities
• Rising global cancer prevalence and screening programs.
• Increasing demand for AI-powered biopsy guidance and digital pathology.
• Expansion into emerging markets with growing healthcare infrastructure.
Biopsy Devices Market Challenges
• High cost of advanced robotic and image-guided systems.
• Regulatory complexities delaying product launches.
• Competition from non-invasive alternatives such as liquid biopsy.
• Shortage of trained healthcare professionals to operate advanced systems.
Analysts Commentary on Biopsy Devices Market
The biopsy devices market is undergoing rapid transformation, fueled by rising cancer incidence, demand for minimally invasive diagnostics, and cutting-edge technological innovations. North America continues to dominate the global landscape, while Asia-Pacific emerges as the fastest-growing region. With AI integration, robotic platforms, and digital pathology set to redefine diagnostics, the biopsy devices market will remain a cornerstone of global cancer detection and management through 2032.
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Rising Cancer Burden and Technological Advancements, states DelveInsight here
News-ID: 4192658 • Views: …
More Releases from DelveInsight Business Research
Global Tumor Ablation Market to reach USD 4,595.68 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The global Tumor Ablations (EHR) market is experiencing significant growth, driven by the increasing prevalence of chronic diseases that require continuous monitoring, data management, and coordinated long-term care. This demand has fueled the need for integrated healthcare systems capable of connecting patient information across multiple departments and care settings. To support this trend, governments worldwide are introducing initiatives, funding, mandates, and regulatory frameworks to promote EHR…
Global Spinal Implants Market to reach USD 21,899.24 million by 2032 at a CAGR o …
According to DelveInsight's analysis, The increasing prevalence of spinal disorders, especially among the aging population, has substantially driven the demand for corrective surgical procedures. At the same time, the rise in sports-related and trauma-induced spinal injuries is boosting the need for advanced implantable solutions. Additionally, there is a growing preference for non-fusion and motion-preserving devices that maintain spinal mobility and improve patient outcomes, particularly among younger and more active individuals.…
Global Vascular Stents Market to reach USD 18,277.68 million by 2032 at a CAGR o …
According to DelveInsight's analysis, The increasing global incidence of cancer is boosting the demand for effective treatment options such as tumor ablation. Minimally invasive procedures are becoming more popular due to their shorter recovery periods, reduced risks, and cost-effectiveness compared to conventional surgery. At the same time, technological advancements in tumor ablation devices-such as improvements in radiofrequency, microwave, and cryoablation technologies-have enhanced precision, safety, and effectiveness, making these procedures increasingly…
Global Vascular Grafts Market to reach USD 3,153.39 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The increasing prevalence of cardiovascular disorders, along with risk factors like hypertension, diabetes, and obesity, is fueling the demand for surgical interventions, thereby supporting the growth of the vascular graft market. Moreover, greater awareness and the expansion of cardiovascular screening programs are enabling earlier diagnosis and timely treatment, further driving the need for vascular grafts.
DelveInsight's "Vascular Grafts Market Insights, Competitive Landscape and Market Forecast-2032" report provides…
More Releases for Biopsy
Liquid Biopsy Market - Unlocking Insights in Liquid: Transforming the Biopsy Lan …
Newark, New Castle, USA: The "Liquid Biopsy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Liquid Biopsy Market: https://www.growthplusreports.com/report/liquid-biopsy-market/8430
This latest report researches the industry structure, sales, revenue,…
Biopsy Devices Market Overview by Breast Biopsy, Lung Biopsy, Prostate Biopsy to …
Download Free PDF Sample Papers Now at Biopsy Devices Market https://www.reportsnreports.com/contacts/requestsample.aspx?name=1159148 .
Biopsy devices market report analyzes various types of biopsy devices in market and their adoption patterns. It aims at estimating market size and future growth potential of biopsy devices market for different segments such as product, guidance technique, application, end user, and region. Global biopsy devices market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East…
Biopsy Device Market to Increase to US$ 2,621 Mn by 2026 | Guidance System (Ster …
Key players focussing on strategic M&A for amplified market shares
Patients are increasingly preferring minimally invasive surgical procedures in order to avoid conventional surgical complications and side-effects, promoting sales of biopsy devices, leading to the growth of the biopsy devices globally. In addition to enabling the accurate diagnosis, a biopsy device assures minimal patient discomfort and trauma. This is identified to be a major factor impacting the popularity of biopsy, and…
Breast Biopsy Market Report 2018: Segmentation by Product (Vacuum Assisted Biops …
Global Breast Biopsy market research report provides company profile for Hologic Inc., Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.), C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule medical Devices LLC. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume,…
Biopsy Devices Market Report 2018: Segmentation by Product (Core Needle Biopsy, …
Global Biopsy Devices market research report provides company profile for C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth…
Bone Biopsy Market 2018 | Needle Biopsy | Open Biopsy | Bone Cancer | Bone Infec …
The Global Bone Biopsy Market is growing continuously and expected to grow at a CAGR of 5.7% from 2017 to 2023. Bone biopsy is performed to diagnose various bone disorders such as bone cancer, bone infection, osteoporosis and chronic kidney disease. Nowadays, biopsy procedure has received great importance in oncology as one of the promising methods in cancer diagnostics. The demand for needle biopsy is found to be increasing from…
